Drugs Launched

We introduce pharmaceuticals launched through our R&D cooperation.

Prostaglandin E1 for intravenous infusion

Palux Injection (5 μg, 10 μg)
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.

Riple Injection (5 μg, 10 μg)
Mitsubishi Tanabe Pharma Corporation

Kaishi Injection (5μg/10μg)
Beijing Tide Pharmaceutical Co., Ltd.

Dexamethasone palmitate for intravenous injection

Rimetasone
Mitsubishi Tanabe Pharma Corporation

Non-steroidal anti-inflammatory analgesic for intravenous infusion.

Ropion Injection
KAKEN PHARMACEUTICAL CO.,LTD.

Kaifeng Injection
Beijing Tide Pharmaceutical Co., Ltd.

Transdermal Steroids

Farnesone
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.

Farenerat
Dainippon Sumitomo Pharma Co., Ltd.

Steroids for guanxi injection

Haloart Injection
Taiho Pharmaceutical Co.

• PALUX is a preparation for which the trademark is registered by  TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
• Ripple is a preparation for which Mitsubishi Tanabe Pharma Corporation has registered a trademark.
• Kaishi is a trademarked formulation of Beijing Tide Pharmaceutical Co., Ltd.
• Rimetasone is a drug product for which Mitsubishi Tanabe Pharma Corporation has registered a trademark.
• Lopion is a preparation for which the trademark is registered by  KAKEN PHARMACEUTICAL CO.,LTD. 
• Kaifeng is a trademark-registered formulation of Beijing Tide Pharmaceutical Co., Ltd.
• Farnesone Gel is a formulation for which the trademark is registered by TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
• Farnelate Gel is a preparation for which the trademark is registered by Dainippon Sumitomo Pharma Co., Ltd.
• Haloart is a preparation for which the trademark is registered by TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.